465
Participants
Start Date
January 12, 2024
Primary Completion Date
July 23, 2024
Study Completion Date
July 23, 2024
HSK3486
HSK3486 for induction of general anesthesia
Propofol
Propofol for induction of general anesthesia
M3-Emerging Medical Research, LLC, Durham
Duke University Medical Center (DUMC), Durham
EBGS Clinical Research Center, Snellville
Atlanta Center for Medical Research, Atlanta
University of Miami Hospital, Miami
Phoenix Clinical Research, LLC, Tamarac
ForCare Clinical Research, Tampa
Gulfcoast Research Institute, Sarasota
North Alabama Medical Center, Florence
Helen Keller Hospital, Sheffield
U of L Health, University of Louisville Hospital, Louisville
The Ohio State University Wexner Medical Center - University Hospital, Columbus
Michigan Medicine, Ann Arbor
University of Iowa Hospitals and Clinics (Dept of Anesthesia), Iowa City
Legent Orthopedic Hospital, Carrollton
The University of Texas MD Anderson Cancer Center, Houston
Memorial Hermann Village, Houston
First Surgical Hospital, Bellaire
Clinical Trials of Texas, LLC, San Antonio
Endeavor Clinical Trials, LLC, San Antonio
The Brigham and Women's Hospital, Boston
Uniwersytecki Szpital Kliniczny W Opolu, Opole
Państwowy Instytut Medyczny Mswia - Klinika Anestezjologii I Intensywnej Terapii, Warsaw
Spsk Nr 1 Im. Prof. S. Szyszko, Zabrze
Hospital Clinic De Barcelona, Barcelona
Hospital General Universitario De Ciudad Real, Ciudad Real
Universidad de Navarra - Clinica Universidad de Navarra en Pamplona, Pamplona
Hospital Clinico Universitario de Valencia (CHUV), Valencia
Lead Sponsor
Haisco-USA Pharmaceuticals, Inc.
INDUSTRY